ID   PE2R4_RAT               Reviewed;         488 AA.
AC   P43114; O08728;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   08-NOV-2023, entry version 152.
DE   RecName: Full=Prostaglandin E2 receptor EP4 subtype;
DE            Short=PGE receptor EP4 subtype;
DE            Short=PGE2 receptor EP4 subtype;
DE   AltName: Full=Prostanoid EP4 receptor;
GN   Name=Ptger4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Lung;
RX   PubMed=8185583; DOI=10.1006/bbrc.1994.1596;
RA   Sando T., Usui T., Tanaka I., Mori K., Sasaki Y., Fukuda Y., Namba T.,
RA   Sugimoto Y., Ichikawa A., Narumiya S., Nakao K.;
RT   "Molecular cloning and expression of rat prostaglandin E receptor EP2
RT   subtype.";
RL   Biochem. Biophys. Res. Commun. 200:1329-1333(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Kidney;
RX   PubMed=9537820; DOI=10.1016/s0014-2999(97)01383-6;
RA   Boie Y., Stocco R., Sawyer N., Slipetz D.M., Ungrin M.D.,
RA   Neuschafer-Rube F., Puschel G.P., Metters K.M., Abramovitz M.;
RT   "Molecular cloning and characterization of the four rat prostaglandin E2
RT   prostanoid receptor subtypes.";
RL   Eur. J. Pharmacol. 340:227-241(1997).
CC   -!- FUNCTION: Receptor for prostaglandin E2 (PGE2). The activity of this
CC       receptor is mediated by G(s) proteins that stimulate adenylate cyclase.
CC       Has a relaxing effect on smooth muscle. May play an important role in
CC       regulating renal hemodynamics, intestinal epithelial transport, adrenal
CC       aldosterone secretion, and uterine function.
CC   -!- SUBUNIT: Interacts with FEM1A. {ECO:0000250|UniProtKB:P35408}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Multi-pass membrane protein.
CC   -!- PTM: Phosphorylation mediates agonist-mediated desensitization by
CC       promoting cytoplasmic retention. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   -!- CAUTION: Was originally designated as the EP2 subtype. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D28860; BAA06011.1; -; mRNA.
DR   EMBL; U94709; AAB53326.1; -; mRNA.
DR   PIR; JC2241; JC2241.
DR   RefSeq; NP_114465.3; NM_032076.3.
DR   RefSeq; XP_006232058.1; XM_006231996.3.
DR   AlphaFoldDB; P43114; -.
DR   SMR; P43114; -.
DR   STRING; 10116.ENSRNOP00000017886; -.
DR   BindingDB; P43114; -.
DR   ChEMBL; CHEMBL4086; -.
DR   DrugCentral; P43114; -.
DR   GuidetoPHARMACOLOGY; 343; -.
DR   GlyCosmos; P43114; 1 site, No reported glycans.
DR   GlyGen; P43114; 1 site.
DR   PhosphoSitePlus; P43114; -.
DR   PaxDb; 10116-ENSRNOP00000017886; -.
DR   GeneID; 84023; -.
DR   KEGG; rno:84023; -.
DR   AGR; RGD:628641; -.
DR   CTD; 5734; -.
DR   RGD; 628641; Ptger4.
DR   eggNOG; KOG3656; Eukaryota.
DR   InParanoid; P43114; -.
DR   OrthoDB; 5355693at2759; -.
DR   PhylomeDB; P43114; -.
DR   TreeFam; TF324982; -.
DR   Reactome; R-RNO-391908; Prostanoid ligand receptors.
DR   PRO; PR:P43114; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0044306; C:neuron projection terminus; IDA:RGD.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0031965; C:nuclear membrane; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0004957; F:prostaglandin E receptor activity; IDA:RGD.
DR   GO; GO:0007189; P:adenylate cyclase-activating G protein-coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007188; P:adenylate cyclase-modulating G protein-coupled receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060348; P:bone development; IDA:UniProtKB.
DR   GO; GO:0071333; P:cellular response to glucose stimulus; IEP:RGD.
DR   GO; GO:0071347; P:cellular response to interleukin-1; IEP:RGD.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; ISS:UniProtKB.
DR   GO; GO:0071380; P:cellular response to prostaglandin E stimulus; IEP:RGD.
DR   GO; GO:0042466; P:chemokinesis; IMP:RGD.
DR   GO; GO:0097070; P:ductus arteriosus closure; IMP:RGD.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; IDA:UniProtKB.
DR   GO; GO:0007565; P:female pregnancy; IEP:RGD.
DR   GO; GO:0006955; P:immune response; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0007254; P:JNK cascade; IDA:UniProtKB.
DR   GO; GO:0060137; P:maternal process involved in parturition; IEP:RGD.
DR   GO; GO:0001818; P:negative regulation of cytokine production; ISS:UniProtKB.
DR   GO; GO:1904336; P:negative regulation of ductus arteriosus closure; IMP:RGD.
DR   GO; GO:1904471; P:negative regulation of endothelin production; IMP:RGD.
DR   GO; GO:2000420; P:negative regulation of eosinophil extravasation; ISS:UniProtKB.
DR   GO; GO:0010727; P:negative regulation of hydrogen peroxide metabolic process; IMP:RGD.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0033624; P:negative regulation of integrin activation; ISS:UniProtKB.
DR   GO; GO:0032690; P:negative regulation of interleukin-1 alpha production; IMP:RGD.
DR   GO; GO:0051771; P:negative regulation of nitric-oxide synthase biosynthetic process; IMP:RGD.
DR   GO; GO:0002792; P:negative regulation of peptide secretion; IMP:RGD.
DR   GO; GO:1904348; P:negative regulation of small intestine smooth muscle contraction; IMP:RGD.
DR   GO; GO:0032720; P:negative regulation of tumor necrosis factor production; IMP:RGD.
DR   GO; GO:2000388; P:positive regulation of antral ovarian follicle growth; IMP:RGD.
DR   GO; GO:0045780; P:positive regulation of bone resorption; IMP:RGD.
DR   GO; GO:1904364; P:positive regulation of calcitonin secretion; IMP:RGD.
DR   GO; GO:0043950; P:positive regulation of cAMP-mediated signaling; IMP:RGD.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:RGD.
DR   GO; GO:1904367; P:positive regulation of chemokinesis; IMP:RGD.
DR   GO; GO:0046010; P:positive regulation of circadian sleep/wake cycle, non-REM sleep; IMP:RGD.
DR   GO; GO:0001819; P:positive regulation of cytokine production; ISS:UniProtKB.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; IBA:GO_Central.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:RGD.
DR   GO; GO:1900127; P:positive regulation of hyaluronan biosynthetic process; IMP:RGD.
DR   GO; GO:0050729; P:positive regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0032733; P:positive regulation of interleukin-10 production; IMP:RGD.
DR   GO; GO:0032757; P:positive regulation of interleukin-8 production; IMP:RGD.
DR   GO; GO:1904466; P:positive regulation of matrix metallopeptidase secretion; IMP:RGD.
DR   GO; GO:0070257; P:positive regulation of mucus secretion; IMP:RGD.
DR   GO; GO:2000391; P:positive regulation of neutrophil extravasation; IMP:RGD.
DR   GO; GO:0045778; P:positive regulation of ossification; IMP:RGD.
DR   GO; GO:0045669; P:positive regulation of osteoblast differentiation; IMP:RGD.
DR   GO; GO:2000386; P:positive regulation of ovarian follicle development; IMP:RGD.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IMP:RGD.
DR   GO; GO:0050714; P:positive regulation of protein secretion; IMP:RGD.
DR   GO; GO:0014911; P:positive regulation of smooth muscle cell migration; IMP:RGD.
DR   GO; GO:1904460; P:positive regulation of substance P secretion; IMP:RGD.
DR   GO; GO:1904496; P:positive regulation of substance P secretion, neurotransmission; IMP:RGD.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; IMP:RGD.
DR   GO; GO:0035810; P:positive regulation of urine volume; IMP:RGD.
DR   GO; GO:0090303; P:positive regulation of wound healing; IMP:RGD.
DR   GO; GO:0010840; P:regulation of circadian sleep/wake cycle, wakefulness; IMP:RGD.
DR   GO; GO:0030278; P:regulation of ossification; ISO:RGD.
DR   GO; GO:0051492; P:regulation of stress fiber assembly; ISS:UniProtKB.
DR   GO; GO:0043200; P:response to amino acid; IEP:RGD.
DR   GO; GO:0070555; P:response to interleukin-1; IEP:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; ISO:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; ISO:RGD.
DR   GO; GO:0009624; P:response to nematode; ISO:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IEP:RGD.
DR   GO; GO:0032570; P:response to progesterone; IEP:RGD.
DR   GO; GO:0034695; P:response to prostaglandin E; IEP:RGD.
DR   GO; GO:1902074; P:response to salt; IEP:RGD.
DR   GO; GO:1990785; P:response to water-immersion restraint stress; IEP:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0042093; P:T-helper cell differentiation; ISS:UniProtKB.
DR   CDD; cd15142; 7tmA_PGE2_EP4; 1.
DR   Gene3D; 1.20.1070.10; Rhodopsin 7-helix transmembrane proteins; 1.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR001758; Prost_EP4_rcpt.
DR   InterPro; IPR008365; Prostanoid_rcpt.
DR   InterPro; IPR001244; Prostglndn_DP_rcpt.
DR   PANTHER; PTHR11866; G-PROTEIN COUPLED RECEPTOR FAMILY 1 MEMBER; 1.
DR   PANTHER; PTHR11866:SF6; PROSTAGLANDIN E2 RECEPTOR EP4 SUBTYPE; 1.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR00428; PROSTAGLNDNR.
DR   PRINTS; PR01788; PROSTANOIDR.
DR   PRINTS; PR00586; PRSTNOIDEP4R.
DR   SUPFAM; SSF81321; Family A G protein-coupled receptor-like; 1.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Disulfide bond; G-protein coupled receptor; Glycoprotein;
KW   Membrane; Phosphoprotein; Receptor; Reference proteome; Transducer;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN           1..488
FT                   /note="Prostaglandin E2 receptor EP4 subtype"
FT                   /id="PRO_0000070068"
FT   TOPO_DOM        1..19
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        20..43
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        44..55
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        56..79
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        80..96
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        97..115
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        116..135
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        136..160
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        161..184
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        185..211
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        212..270
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        271..298
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        299..315
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        316..335
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        336..488
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          358..380
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35408"
FT   MOD_RES         380
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35408"
FT   MOD_RES         382
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35408"
FT   MOD_RES         385
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35408"
FT   CARBOHYD        7
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        92..170
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   CONFLICT        214
FT                   /note="L -> H (in Ref. 2; AAB53326)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        396
FT                   /note="H -> Q (in Ref. 2; AAB53326)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   488 AA;  53366 MW;  C2EE713018723FF4 CRC64;
     MSIPGVNASF SSTPERLNSP VTIPAVMFIF GVVGNLVAIV VLCKSRKEQK ETTFYTLVCG
     LAVTDLLGTL LVSPVTIATY MKGQWPGDQA LCDYSTFILL FFGLSGLSII CAMSIERYLA
     INHAYFYSHY VDKRLAGLTL FAVYASNVLF CALPNMGLGR SERQYPGTWC FIDWTTNVTA
     YAAFSYMYAG FSSFLILATV LCNVLVCGAL LRMLRQFMRR TSLGTEQHHA AAAAAVASVA
     CRGHAAASPA LQRLSDFRRR RSFRRIAGAE IQMVILLIAT SLVVLICSIP LVVRVFINQL
     YQPSVVKDIS RNPDLQAIRI ASVNPILDPW IYILLRKTVL SKAIEKIKCL FCRIGGSGRD
     GSAQHCSESR RTSSAMSGHS RSFLSRELRE ISSTSHTLLY LPDLTESSLG GKNLLPGTHG
     MGLTQADTTS LRTLRISETS DSSQGQDSES VLLVDEVSGS QREEPASKGN SLQVTFPSET
     LKLSEKCI
//
